Rita Saúde-Conde - Search Results

Year	Number of Results
2021	3
2022	4
2023	3
2024	1

1

Immunotherapies in non-metastatic gastrointestinal cancers.

Saúde-Conde R, Nguyen D, Hendlisz A. Saúde-Conde R, et al. Curr Opin Oncol. 2023 Jul 1;35(4):334-346. doi: 10.1097/CCO.0000000000000956. Epub 2023 May 9. Curr Opin Oncol. 2023. PMID: 37222204

2

The emerging role of immunotherapy in the treatment of anal cancer.

Saúde-Conde R, Parisi A, Giunta EF, Meyers M, Sclafani F. Saúde-Conde R, et al. Curr Opin Pharmacol. 2022 Dec;67:102309. doi: 10.1016/j.coph.2022.102309. Epub 2022 Oct 27. Curr Opin Pharmacol. 2022. PMID: 36334330 Review.

3

Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.

Akin Telli T, Bregni G, Vanhooren M, Saude Conde R, Hendlisz A, Sclafani F. Akin Telli T, et al. Among authors: saude conde r. Cancer Treat Rev. 2022 Nov;110:102460. doi: 10.1016/j.ctrv.2022.102460. Epub 2022 Aug 27. Cancer Treat Rev. 2022. PMID: 36058142 Review.

4

The Exciting New Field of HER2-Low Breast Cancer Treatment.

Eiger D, Agostinetto E, Saúde-Conde R, de Azambuja E. Eiger D, et al. Among authors: saude conde r. Cancers (Basel). 2021 Mar 1;13(5):1015. doi: 10.3390/cancers13051015. Cancers (Basel). 2021. PMID: 33804398 Free PMC article. Review.

5

Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.

Saúde-Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F. Saúde-Conde R, et al. Curr Opin Oncol. 2022 Jul 1;34(4):382-388. doi: 10.1097/CCO.0000000000000842. Epub 2022 Jun 22. Curr Opin Oncol. 2022. PMID: 35730499 Review.

6

JCOG0603: Are We Really Sure This Was a Negative Trial?

Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F. Saude Conde R, et al. J Clin Oncol. 2022 Mar 1;40(7):803-805. doi: 10.1200/JCO.21.02299. Epub 2022 Jan 13. J Clin Oncol. 2022. PMID: 35025615 No abstract available.

7

Targeted agents in older patients with gastrointestinal cancers - An overview.

Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L. Monteiro AR, et al. Among authors: conde rs. J Geriatr Oncol. 2021 Nov;12(8):1240-1252. doi: 10.1016/j.jgo.2021.06.013. Epub 2021 Jul 2. J Geriatr Oncol. 2021. PMID: 34226158 Review.

8

Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.

Assaf I, Fimereli D, Anthoine G, Fazio R, Daprà V, Audisio A, Bardiaux A, Telli TA, Vanhooren M, Saude-Conde R, Bregni G, Hendlisz A, Sclafani F. Assaf I, et al. Among authors: saude conde r. Cancers (Basel). 2023 Dec 13;15(24):5823. doi: 10.3390/cancers15245823. Cancers (Basel). 2023. PMID: 38136368 Free PMC article.

9

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging.

Saúde-Conde R, Arçay Öztürk A, Stosic K, Azurmendi Senar O, Navez J, Bouchart C, Arsenijevic T, Flamen P, Van Laethem JL. Saúde-Conde R, et al. Biomedicines. 2024 Mar 6;12(3):591. doi: 10.3390/biomedicines12030591. Biomedicines. 2024. PMID: 38540204 Free PMC article. Review.

10

Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.

Bregni G, Trevisi E, Saúde Conde R, Vanhooren M, Akin Telli T, Assaf I, Hendlisz A, Di Maio M, Sclafani F. Bregni G, et al. Among authors: saude conde r. J Natl Cancer Inst. 2023 May 8;115(5):505-513. doi: 10.1093/jnci/djad030. J Natl Cancer Inst. 2023. PMID: 36762842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year